Literature DB >> 28783541

Increasing frequency of non-smoking lung cancer: Presentation of patients with early disease to a tertiary institution in the UK.

Maria Elena Cufari1, Chiara Proli1, Paulo De Sousa1, Hilgardt Raubenheimer1, May Al Sahaf1, Hema Chavan1, Lynn Shedden1, Zakiyah Niwaz1, Maria Leung1, Andrew G Nicholson1, Vladimir Anikin1, Emma Beddow1, Niall McGonigle1, Michael E Dusmet1, Simon Jordan1, George Ladas1, Eric Lim2.   

Abstract

BACKGROUND: Never-smokers with lung cancer often present late as there are no established aetiological risk factors. The aim of the study is to define the frequency over time and characterise clinical features of never-smokers presenting sufficiently early to determine if it is possible to identify patients at risk.
METHODS: We retrospectively analysed data from a prospectively collected database of patients who underwent surgery. The frequency was defined as number of never-smokers versus current and ex-smokers by year. Clinical features at presentation were collated as frequency.
RESULTS: A total of 2170 patients underwent resection for lung cancer from March 2008 to November 2014. The annual frequency of developing lung cancer in never-smokers increased from 13% to 28%, attributable to an absolute increase in numbers and not simply a change in the ratio of never-smokers to current and ex-smokers. A total of 436 (20%) patients were never-smokers. The mean age was 60 (16 SD) years and 67% were female. Presenting features were non-specific consisting of cough in 34%, chest infections in 18% and haemoptysis in 11%. A total of 14% were detected on incidental chest film, 30% on computed tomography, 7% on positron-emission tomography/computed tomography and 1% on MRI.
CONCLUSIONS: We observed more than a double of the annual frequency of never-smokers in the last 7 years. Patients present with non-specific symptoms and majority were detected on incidental imaging, a modality that is likely to play an increasingly important role for early detection in this cohort that does not have any observable clinical risk factors.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mediastinum abnormalities; Mediastinum diagnostic imaging; PET-CT; Smoking

Mesh:

Year:  2017        PMID: 28783541     DOI: 10.1016/j.ejca.2017.06.031

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  11 in total

1.  Detection of circulating tumor cells in patients with lung cancer using metallic micro-cavity array filter: A pilot study.

Authors:  Hideo Ichimura; Takeshi Nawa; Yusuke Yamamoto; Kei Shimizu; Keisuke Kobayashi; Shinsuke Kitazawa; Hisashige Kanbara; Taihei Odagiri; Katsuya Endo; Tatsuya Matsunaga; Seita Nakamura; Satomi Yagi; Yukio Sato
Journal:  Mol Clin Oncol       Date:  2020-01-10

2.  Lung Cancer in Non-Smokers.

Authors:  Sarah Dubin; Daniel Griffin
Journal:  Mo Med       Date:  2020 Jul-Aug

3.  The Role of UK Oncogene-Focussed Patient Groups in Supporting and Educating Patients with Oncogene-Driven NSCLC: Results from a Patient-Devised Survey.

Authors:  Jenny Abbott; Kathleen Beattie; Debra Montague
Journal:  Oncol Ther       Date:  2021-03-07

4.  A population-based cohort study to evaluate the effectiveness of lung cancer screening using low-dose CT in Hitachi city, Japan.

Authors:  Takeshi Nawa; Keisuke Fukui; Tomio Nakayama; Motoyasu Sagawa; Tohru Nakagawa; Hideo Ichimura; Tetsuya Mizoue
Journal:  Jpn J Clin Oncol       Date:  2019-02-01       Impact factor: 3.019

5.  Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study.

Authors:  Akiko Kowada
Journal:  BMC Pulm Med       Date:  2022-01-08       Impact factor: 3.317

Review 6.  The role of gender in non-small cell lung cancer: a narrative review.

Authors:  Ioana Baiu; Ashley L Titan; Linda W Martin; Andrea Wolf; Leah Backhus
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

7.  Differential Effect of Smoking on Gene Expression in Head and Neck Cancer Patients.

Authors:  Alexandra Iulia Irimie; Cornelia Braicu; Roxana Cojocneanu; Lorand Magdo; Anca Onaciu; Cristina Ciocan; Nikolay Mehterov; Diana Dudea; Smaranda Buduru; Ioana Berindan-Neagoe
Journal:  Int J Environ Res Public Health       Date:  2018-07-23       Impact factor: 3.390

8.  Surgically treated lung cancer patients: do they all smoke and would they all have been detected with lung cancer screening?

Authors:  Tanel Laisaar; Bruno Sarana; Indrek Benno; Kaja-Triin Laisaar
Journal:  ERJ Open Res       Date:  2018-08-03

9.  Low-dose CT lung cancer screening in never-smokers and smokers: results of an eight-year observational study.

Authors:  Ryutaro Kakinuma; Yukio Muramatsu; Hisao Asamura; Shun-Ichi Watanabe; Masahiko Kusumoto; Takaaki Tsuchida; Masahiro Kaneko; Koji Tsuta; Akiko Miyagi Maeshima; Genichiro Ishii; Kanji Nagai; Taiki Yamaji; Takahisa Matsuda; Noriyuki Moriyama
Journal:  Transl Lung Cancer Res       Date:  2020-02

Review 10.  Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer.

Authors:  Nuria Mederos; Alex Friedlaender; Solange Peters; Alfredo Addeo
Journal:  ESMO Open       Date:  2020-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.